This inventor holds 1 USPTO granted patent. Top assignee: National Health Research Institutes. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Innovations of Sheng-Ju Hsu in Hepatitis C Treatment
Introduction
Sheng-Ju Hsu is a notable inventor based in Yangmei Town, Taiwan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating viral infections.
Latest Patents
One of his key patents is focused on imidazolidinone and imidazolidinethione derivatives. This patent includes compounds of formula (I), wherein R, R, R, A, A, X, Y, Z, m, n, p, x, and y are defined. The patent also discloses a method for treating hepatitis C virus infection using these innovative compounds. He holds 1 patent in this area.
Career Highlights
Sheng-Ju Hsu is affiliated with the National Health Research Institutes, where he conducts research and development in the field of health sciences. His work has been instrumental in advancing therapeutic options for hepatitis C.
Collaborations
He has collaborated with notable colleagues such as Jyh-Haur Chern and Tsu-An Hsu, contributing to a collaborative environment that fosters innovation and research excellence.
Conclusion
Sheng-Ju Hsu's work in developing new compounds for treating hepatitis C showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile